Showing results (231-240 of 286) with videos related to

Sort By:
Pageof 29
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of Adenocarcinoma of the Vater Papilla Treated with Pancreatoduodenectomy after Hepaticojejunostomy for Prior Adenocarcinoma of the Gallbladder]Yu Takeda, Yoshito Tomimaru, Kozo Noguchi, et al.
Disease Markers|November 28, 2013
CD90- (Thy-1-) high selection enhances reprogramming capacity of murine adipose-derived mesenchymal stem cellsKoichi Kawamoto, Masamitsu Konno, Hiroaki Nagano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Three Resected Cases of Metachronous Pancreatic Cancer Successfully Treated with Repeated Pancreatectomy]Kozo Noguchi, Yoshito Tomimaru, Hidetoshi Eguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Long-Term Survival after Surgical Treatment of Neuroendocrine Carcinoma of the Ampulla of Vater-A Case Report]Ryo Yoshioka, Yoshito Tomimaru, Kozo Noguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[A Case of Resected Primary Hepatic Neuroendocrine Tumor]Naoto Fujimoto, Yoshito Tomimaru, Kozo Noguchi, et al.
Cancer Science|January 11, 2021
Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cellsYuki Yokota, Takehiro Noda, Yuichiro Okumura, et al.
Hepatology (Baltimore, Md.)|July 21, 2012
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesisTokuhiro Matsubara, Tatsuya Kanto, Shoko Kuroda, et al.
Pageof 29